09:12 AM EST, 12/20/2024 (MT Newswires) -- US stocks look set to open lower in Friday's trading session as investors parse better-than-expected inflation data released earlier in the morning.

The stock markets were paring losses from earlier in the morning as Dow Jones Industrial Average futures were down 0.21%, S&P 500 futures were falling 0.48%, and Nasdaq futures were moving 0.84% lower.

Monthly core inflation for November rose 0.1% compared with 0.3% in October and below expectations of a 0.2% rise, according to Bloomberg. Meanwhile the annual core inflation rate held steady at 2.8%, compared with expectations of 2.9%.

Oil prices were moving lower, with front-month global benchmarks Brent crude and West Texas Intermediate crude falling 0.69% and 2.48% respectively.

In other world markets, Japan's Nikkei was down 0.20%, Hong Kong's Hang Seng declined 0.16%, and China's Shanghai Composite was off 0.06%. Meanwhile in Europe's early afternoon session, the UK's FTSE 100 was down 1.2%, while Germany's DAX and France's CAC were moving 1.19% and 1.03% lower respectively.

In equities, shares of My Size ( MYSZ ) soared 340% in Friday's premarket session, adding to a 21% gain on Thursday. Nvni Group ( NVNI ) shares jumped 98% after skyrocketing 317% the previous day. Shares of Psyence Biomedica (PBM) rose 44%, adding to a 61% gain on Thursday. Aptose Biosciences ( APTO ) shares were up 66%, a day after it said the Nasdaq Hearings Panel approved its request for an extension to prove compliance with the minimum bid price requirement for continued listing. And shares of Humacyte ( HUMA ) were advancing 72% after it said late Thursday that the US Food and Drug Administration granted full approval for SYMVESS, a bioengineered human tissue designed to be universally implantable.

On the losing side, shares of Molecular Templates ( MTEM ) plunged 54% after reporting late Thursday that trading of its stock will be suspended Dec. 26 from Nasdaq due to its failure to comply with multiple requirements for continued listing. Shares of Cyngn ( CYN ) fell 75% after losing 4.7% Thursday. Hyzon Motors' ( HYZN ) stock tumbled 25% after it said Friday that it has notified its employees in Illinois and Michigan of pending layoffs. Shares of PainReform ( PRFX ) dropped 36% following a 410% gain on Thursday. And shares of Bio-Path ( BPTH ) lost 17% after rising 123% the previous session.